Sanofi SA vs Tractor Supply Co — how do they compare? Sanofi SA trades at $43.58 (market cap $104.30B), while Tractor Supply Co trades at $36.36 (market cap $18.39B). The key difference: Sanofi SA is far larger — about 5.7× Tractor Supply Co's market cap, and Sanofi SA pays the higher dividend (5.55%). Which is the better fit depends on your goals.
| SNY | TSCO | |
|---|---|---|
Market Cap | $104.30B | $18.39B |
Sector | Health | Consumer Cyclical |
52-Week High | $52.34 | $62.65 |
52-Week Low | $41.33 | $29.14 |
Enterprise Value | $124.19B | $24.70B |
Dividend Yield | 5.55% | 2.72% |
Signals from Pluang's Aura AI — not financial advice
SNY trades at $43.54, up 0.14% today, with a neutral technical signal and bullish moving averages. Recent Q2 2026 earnings beat expectations, with EPS of $1.21 versus $1.10 expected, driven by strong Dupixent sales. The company raised its 2026 outlook, projecting ~10% sales growth. Financial health is solid with a P/E of 23.27 and robust operating cash flow of $10.75B in 2025, though net cash flow was minimal at $49M.
Outlook is cautiously optimistic with growth catalysts from Dupixent and new drug approvals, but risks include pipeline setbacks and competitive pressures. Analysts are mixed, with 44% buy ratings, highlighting potential upside to fair value estimates around $57, while debt levels and regulatory scrutiny pose challenges for sustained shareholder value.
Tractor Supply (TSCO) trades at $36.24, up 4.68% today, with a mixed technical picture showing bullish moving averages but overbought RSI levels. Fundamentally, the company reported $15.52B in 2025 revenue with a net margin of 6.42%, though recent quarters saw EPS misses. Valuation metrics include a P/E of 18.38 and ROE of 39.51%, indicating strong profitability but high price-to-book at 6.99. Recent news highlights CEO share purchases and dividend declarations amid a 2026 outlook cut due to weak demand.
The stock presents a cautious opportunity with solid fundamentals offset by near-term headwinds. Upside potential exists from digital growth and pet initiatives, but risks include discretionary spending pressure and cost inflation. Analysts are divided, with a $36.29 price target suggesting limited upside from current levels, requiring careful monitoring of holiday sales and margin trends.
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →